世界の血液透過性感染症検査市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Hemotransmissive Infections Testing Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2777 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、血液透過性感染症検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（B型肝炎ウイルス（HBV）DNA検査、C型肝炎ウイルス（HCV）RNA検査、ヒト免疫不全ウイルス（HIV）タイプ1・2RNA検査）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・血液透過性感染症検査の市場動向 ・企業の競争状況、市場シェア ・血液透過性感染症検査の種類別市場規模（B型肝炎ウイルス（HBV）DNA検査、C型肝炎ウイルス（HCV）RNA検査、ヒト免疫不全ウイルス（HIV）タイプ1・2RNA検査） ・血液透過性感染症検査の用途別市場規模（病院、クリニック、その他） ・血液透過性感染症検査の北米市場規模2016-2027（アメリカ、カナダ） ・血液透過性感染症検査のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・血液透過性感染症検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・血液透過性感染症検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・血液透過性感染症検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Vector-Best、Atlas Medical、Launch Diagnostics、Creative Diagnostics、Shanghai Chemtron Biotech、Oscar Medicare、ABON Biopharm、Bio-Rad Laboratories、Trinity Biotech Manufacturing、Adaltis） ・結論

Hemotransmissive Infections are the infections which are transferred through blood when infected person comes in contact. Severe diseases such as hepatitis C, hepatitis B and human immunodeficiency virus (HIV) are most common diseases spread via blood. Timely diagnosis of these diseases becomes important for their cure or management.

Market Analysis and Insights: Global Hemotransmissive Infections Testing Market
The global Hemotransmissive Infections Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hemotransmissive Infections Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hemotransmissive Infections Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hemotransmissive Infections Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hemotransmissive Infections Testing market.

Global Hemotransmissive Infections Testing Scope and Market Size
Hemotransmissive Infections Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hemotransmissive Infections Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Hepatitis B virus (HBV) DNA Testing
Hepatitis C virus (HCV) RNA Testing
Human immunodeficiency virus (HIV) types 1 and 2 RNA Testing

Segment by Application
Hospital
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Vector-Best
Atlas Medical
Launch Diagnostics
Creative Diagnostics
Shanghai Chemtron Biotech
Oscar Medicare
ABON Biopharm
Bio-Rad Laboratories
Trinity Biotech Manufacturing

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hemotransmissive Infections Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Hepatitis B virus (HBV) DNA Testing
1.2.3 Hepatitis C virus (HCV) RNA Testing
1.2.4 Human immunodeficiency virus (HIV) types 1 and 2 RNA Testing
1.3 Market by Application
1.3.1 Global Hemotransmissive Infections Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Hemotransmissive Infections Testing Market Perspective (2016-2027)
2.2 Hemotransmissive Infections Testing Growth Trends by Regions
2.2.1 Hemotransmissive Infections Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hemotransmissive Infections Testing Historic Market Share by Regions (2016-2021)
2.2.3 Hemotransmissive Infections Testing Forecasted Market Size by Regions (2022-2027)
2.3 Hemotransmissive Infections Testing Industry Dynamic
2.3.1 Hemotransmissive Infections Testing Market Trends
2.3.2 Hemotransmissive Infections Testing Market Drivers
2.3.3 Hemotransmissive Infections Testing Market Challenges
2.3.4 Hemotransmissive Infections Testing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Hemotransmissive Infections Testing Players by Revenue
3.1.1 Global Top Hemotransmissive Infections Testing Players by Revenue (2016-2021)
3.1.2 Global Hemotransmissive Infections Testing Revenue Market Share by Players (2016-2021)
3.2 Global Hemotransmissive Infections Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hemotransmissive Infections Testing Revenue
3.4 Global Hemotransmissive Infections Testing Market Concentration Ratio
3.4.1 Global Hemotransmissive Infections Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hemotransmissive Infections Testing Revenue in 2020
3.5 Hemotransmissive Infections Testing Key Players Head office and Area Served
3.6 Key Players Hemotransmissive Infections Testing Product Solution and Service
3.7 Date of Enter into Hemotransmissive Infections Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Hemotransmissive Infections Testing Breakdown Data by Type
4.1 Global Hemotransmissive Infections Testing Historic Market Size by Type (2016-2021)
4.2 Global Hemotransmissive Infections Testing Forecasted Market Size by Type (2022-2027)

5 Hemotransmissive Infections Testing Breakdown Data by Application
5.1 Global Hemotransmissive Infections Testing Historic Market Size by Application (2016-2021)
5.2 Global Hemotransmissive Infections Testing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Hemotransmissive Infections Testing Market Size (2016-2027)
6.2 North America Hemotransmissive Infections Testing Market Size by Type
6.2.1 North America Hemotransmissive Infections Testing Market Size by Type (2016-2021)
6.2.2 North America Hemotransmissive Infections Testing Market Size by Type (2022-2027)
6.2.3 North America Hemotransmissive Infections Testing Market Size by Type (2016-2027)
6.3 North America Hemotransmissive Infections Testing Market Size by Application
6.3.1 North America Hemotransmissive Infections Testing Market Size by Application (2016-2021)
6.3.2 North America Hemotransmissive Infections Testing Market Size by Application (2022-2027)
6.3.3 North America Hemotransmissive Infections Testing Market Size by Application (2016-2027)
6.4 North America Hemotransmissive Infections Testing Market Size by Country
6.4.1 North America Hemotransmissive Infections Testing Market Size by Country (2016-2021)
6.4.2 North America Hemotransmissive Infections Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Hemotransmissive Infections Testing Market Size (2016-2027)
7.2 Europe Hemotransmissive Infections Testing Market Size by Type
7.2.1 Europe Hemotransmissive Infections Testing Market Size by Type (2016-2021)
7.2.2 Europe Hemotransmissive Infections Testing Market Size by Type (2022-2027)
7.2.3 Europe Hemotransmissive Infections Testing Market Size by Type (2016-2027)
7.3 Europe Hemotransmissive Infections Testing Market Size by Application
7.3.1 Europe Hemotransmissive Infections Testing Market Size by Application (2016-2021)
7.3.2 Europe Hemotransmissive Infections Testing Market Size by Application (2022-2027)
7.3.3 Europe Hemotransmissive Infections Testing Market Size by Application (2016-2027)
7.4 Europe Hemotransmissive Infections Testing Market Size by Country
7.4.1 Europe Hemotransmissive Infections Testing Market Size by Country (2016-2021)
7.4.2 Europe Hemotransmissive Infections Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Hemotransmissive Infections Testing Market Size (2016-2027)
8.2 Asia-Pacific Hemotransmissive Infections Testing Market Size by Type
8.2.1 Asia-Pacific Hemotransmissive Infections Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hemotransmissive Infections Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hemotransmissive Infections Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Hemotransmissive Infections Testing Market Size by Application
8.3.1 Asia-Pacific Hemotransmissive Infections Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hemotransmissive Infections Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hemotransmissive Infections Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Hemotransmissive Infections Testing Market Size by Region
8.4.1 Asia-Pacific Hemotransmissive Infections Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hemotransmissive Infections Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Hemotransmissive Infections Testing Market Size (2016-2027)
9.2 Latin America Hemotransmissive Infections Testing Market Size by Type
9.2.1 Latin America Hemotransmissive Infections Testing Market Size by Type (2016-2021)
9.2.2 Latin America Hemotransmissive Infections Testing Market Size by Type (2022-2027)
9.2.3 Latin America Hemotransmissive Infections Testing Market Size by Type (2016-2027)
9.3 Latin America Hemotransmissive Infections Testing Market Size by Application
9.3.1 Latin America Hemotransmissive Infections Testing Market Size by Application (2016-2021)
9.3.2 Latin America Hemotransmissive Infections Testing Market Size by Application (2022-2027)
9.3.3 Latin America Hemotransmissive Infections Testing Market Size by Application (2016-2027)
9.4 Latin America Hemotransmissive Infections Testing Market Size by Country
9.4.1 Latin America Hemotransmissive Infections Testing Market Size by Country (2016-2021)
9.4.2 Latin America Hemotransmissive Infections Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Hemotransmissive Infections Testing Market Size (2016-2027)
10.2 Middle East & Africa Hemotransmissive Infections Testing Market Size by Type
10.2.1 Middle East & Africa Hemotransmissive Infections Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hemotransmissive Infections Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hemotransmissive Infections Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Hemotransmissive Infections Testing Market Size by Application
10.3.1 Middle East & Africa Hemotransmissive Infections Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hemotransmissive Infections Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hemotransmissive Infections Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Hemotransmissive Infections Testing Market Size by Country
10.4.1 Middle East & Africa Hemotransmissive Infections Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hemotransmissive Infections Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Vector-Best
11.1.1 Vector-Best Company Details
11.1.2 Vector-Best Business Overview
11.1.3 Vector-Best Hemotransmissive Infections Testing Introduction
11.1.4 Vector-Best Revenue in Hemotransmissive Infections Testing Business (2016-2021)
11.1.5 Vector-Best Recent Development
11.2 Atlas Medical
11.2.1 Atlas Medical Company Details
11.2.2 Atlas Medical Business Overview
11.2.3 Atlas Medical Hemotransmissive Infections Testing Introduction
11.2.4 Atlas Medical Revenue in Hemotransmissive Infections Testing Business (2016-2021)
11.2.5 Atlas Medical Recent Development
11.3 Launch Diagnostics
11.3.1 Launch Diagnostics Company Details
11.3.2 Launch Diagnostics Business Overview
11.3.3 Launch Diagnostics Hemotransmissive Infections Testing Introduction
11.3.4 Launch Diagnostics Revenue in Hemotransmissive Infections Testing Business (2016-2021)
11.3.5 Launch Diagnostics Recent Development
11.4 Creative Diagnostics
11.4.1 Creative Diagnostics Company Details
11.4.2 Creative Diagnostics Business Overview
11.4.3 Creative Diagnostics Hemotransmissive Infections Testing Introduction
11.4.4 Creative Diagnostics Revenue in Hemotransmissive Infections Testing Business (2016-2021)
11.4.5 Creative Diagnostics Recent Development
11.5 Shanghai Chemtron Biotech
11.5.1 Shanghai Chemtron Biotech Company Details
11.5.2 Shanghai Chemtron Biotech Business Overview
11.5.3 Shanghai Chemtron Biotech Hemotransmissive Infections Testing Introduction
11.5.4 Shanghai Chemtron Biotech Revenue in Hemotransmissive Infections Testing Business (2016-2021)
11.5.5 Shanghai Chemtron Biotech Recent Development
11.6 Oscar Medicare
11.6.1 Oscar Medicare Company Details
11.6.2 Oscar Medicare Business Overview
11.6.3 Oscar Medicare Hemotransmissive Infections Testing Introduction
11.6.4 Oscar Medicare Revenue in Hemotransmissive Infections Testing Business (2016-2021)
11.6.5 Oscar Medicare Recent Development
11.7 ABON Biopharm
11.7.1 ABON Biopharm Company Details
11.7.2 ABON Biopharm Business Overview
11.7.3 ABON Biopharm Hemotransmissive Infections Testing Introduction
11.7.4 ABON Biopharm Revenue in Hemotransmissive Infections Testing Business (2016-2021)
11.7.5 ABON Biopharm Recent Development
11.8 Bio-Rad Laboratories
11.8.1 Bio-Rad Laboratories Company Details
11.8.2 Bio-Rad Laboratories Business Overview
11.8.3 Bio-Rad Laboratories Hemotransmissive Infections Testing Introduction
11.8.4 Bio-Rad Laboratories Revenue in Hemotransmissive Infections Testing Business (2016-2021)
11.8.5 Bio-Rad Laboratories Recent Development
11.9 Trinity Biotech Manufacturing
11.9.1 Trinity Biotech Manufacturing Company Details
11.9.2 Trinity Biotech Manufacturing Business Overview
11.9.3 Trinity Biotech Manufacturing Hemotransmissive Infections Testing Introduction
11.9.4 Trinity Biotech Manufacturing Revenue in Hemotransmissive Infections Testing Business (2016-2021)
11.9.5 Trinity Biotech Manufacturing Recent Development
11.10 Adaltis
11.10.1 Adaltis Company Details
11.10.2 Adaltis Business Overview
11.10.3 Adaltis Hemotransmissive Infections Testing Introduction
11.10.4 Adaltis Revenue in Hemotransmissive Infections Testing Business (2016-2021)
11.10.5 Adaltis Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Hemotransmissive Infections Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Hepatitis B virus (HBV) DNA Testing
Table 3. Key Players of Hepatitis C virus (HCV) RNA Testing
Table 4. Key Players of Human immunodeficiency virus (HIV) types 1 and 2 RNA Testing
Table 5. Global Hemotransmissive Infections Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Hemotransmissive Infections Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Hemotransmissive Infections Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Hemotransmissive Infections Testing Market Share by Regions (2016-2021)
Table 9. Global Hemotransmissive Infections Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Hemotransmissive Infections Testing Market Share by Regions (2022-2027)
Table 11. Hemotransmissive Infections Testing Market Trends
Table 12. Hemotransmissive Infections Testing Market Drivers
Table 13. Hemotransmissive Infections Testing Market Challenges
Table 14. Hemotransmissive Infections Testing Market Restraints
Table 15. Global Hemotransmissive Infections Testing Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Hemotransmissive Infections Testing Market Share by Players (2016-2021)
Table 17. Global Top Hemotransmissive Infections Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemotransmissive Infections Testing as of 2020)
Table 18. Ranking of Global Top Hemotransmissive Infections Testing Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Hemotransmissive Infections Testing Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Hemotransmissive Infections Testing Product Solution and Service
Table 22. Date of Enter into Hemotransmissive Infections Testing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Hemotransmissive Infections Testing Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Hemotransmissive Infections Testing Revenue Market Share by Type (2016-2021)
Table 26. Global Hemotransmissive Infections Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Hemotransmissive Infections Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Hemotransmissive Infections Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Hemotransmissive Infections Testing Revenue Market Share by Application (2016-2021)
Table 30. Global Hemotransmissive Infections Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Hemotransmissive Infections Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Hemotransmissive Infections Testing Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Hemotransmissive Infections Testing Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Hemotransmissive Infections Testing Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Hemotransmissive Infections Testing Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Hemotransmissive Infections Testing Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Hemotransmissive Infections Testing Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Hemotransmissive Infections Testing Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Hemotransmissive Infections Testing Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Hemotransmissive Infections Testing Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Hemotransmissive Infections Testing Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Hemotransmissive Infections Testing Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Hemotransmissive Infections Testing Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Hemotransmissive Infections Testing Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Hemotransmissive Infections Testing Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Hemotransmissive Infections Testing Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Hemotransmissive Infections Testing Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Hemotransmissive Infections Testing Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Hemotransmissive Infections Testing Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Hemotransmissive Infections Testing Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Hemotransmissive Infections Testing Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Hemotransmissive Infections Testing Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Hemotransmissive Infections Testing Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Hemotransmissive Infections Testing Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Hemotransmissive Infections Testing Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Hemotransmissive Infections Testing Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Hemotransmissive Infections Testing Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Hemotransmissive Infections Testing Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Hemotransmissive Infections Testing Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Hemotransmissive Infections Testing Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Hemotransmissive Infections Testing Market Size by Country (2022-2027) & (US$ Million)
Table 62. Vector-Best Company Details
Table 63. Vector-Best Business Overview
Table 64. Vector-Best Hemotransmissive Infections Testing Product
Table 65. Vector-Best Revenue in Hemotransmissive Infections Testing Business (2016-2021) & (US$ Million)
Table 66. Vector-Best Recent Development
Table 67. Atlas Medical Company Details
Table 68. Atlas Medical Business Overview
Table 69. Atlas Medical Hemotransmissive Infections Testing Product
Table 70. Atlas Medical Revenue in Hemotransmissive Infections Testing Business (2016-2021) & (US$ Million)
Table 71. Atlas Medical Recent Development
Table 72. Launch Diagnostics Company Details
Table 73. Launch Diagnostics Business Overview
Table 74. Launch Diagnostics Hemotransmissive Infections Testing Product
Table 75. Launch Diagnostics Revenue in Hemotransmissive Infections Testing Business (2016-2021) & (US$ Million)
Table 76. Launch Diagnostics Recent Development
Table 77. Creative Diagnostics Company Details
Table 78. Creative Diagnostics Business Overview
Table 79. Creative Diagnostics Hemotransmissive Infections Testing Product
Table 80. Creative Diagnostics Revenue in Hemotransmissive Infections Testing Business (2016-2021) & (US$ Million)
Table 81. Creative Diagnostics Recent Development
Table 82. Shanghai Chemtron Biotech Company Details
Table 83. Shanghai Chemtron Biotech Business Overview
Table 84. Shanghai Chemtron Biotech Hemotransmissive Infections Testing Product
Table 85. Shanghai Chemtron Biotech Revenue in Hemotransmissive Infections Testing Business (2016-2021) & (US$ Million)
Table 86. Shanghai Chemtron Biotech Recent Development
Table 87. Oscar Medicare Company Details
Table 88. Oscar Medicare Business Overview
Table 89. Oscar Medicare Hemotransmissive Infections Testing Product
Table 90. Oscar Medicare Revenue in Hemotransmissive Infections Testing Business (2016-2021) & (US$ Million)
Table 91. Oscar Medicare Recent Development
Table 92. ABON Biopharm Company Details
Table 93. ABON Biopharm Business Overview
Table 94. ABON Biopharm Hemotransmissive Infections Testing Product
Table 95. ABON Biopharm Revenue in Hemotransmissive Infections Testing Business (2016-2021) & (US$ Million)
Table 96. ABON Biopharm Recent Development
Table 97. Bio-Rad Laboratories Company Details
Table 98. Bio-Rad Laboratories Business Overview
Table 99. Bio-Rad Laboratories Revenue in Hemotransmissive Infections Testing Business (2016-2021) & (US$ Million)
Table 100. Bio-Rad Laboratories Recent Development
Table 101. Trinity Biotech Manufacturing Company Details
Table 102. Trinity Biotech Manufacturing Business Overview
Table 103. Trinity Biotech Manufacturing Hemotransmissive Infections Testing Product
Table 104. Trinity Biotech Manufacturing Revenue in Hemotransmissive Infections Testing Business (2016-2021) & (US$ Million)
Table 105. Trinity Biotech Manufacturing Recent Development
Table 106. Adaltis Company Details
Table 107. Adaltis Business Overview
Table 108. Adaltis Hemotransmissive Infections Testing Product
Table 109. Adaltis Revenue in Hemotransmissive Infections Testing Business (2016-2021) & (US$ Million)
Table 110. Adaltis Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hemotransmissive Infections Testing Market Share by Type: 2020 VS 2027
Figure 2. Hepatitis B virus (HBV) DNA Testing Features
Figure 3. Hepatitis C virus (HCV) RNA Testing Features
Figure 4. Human immunodeficiency virus (HIV) types 1 and 2 RNA Testing Features
Figure 5. Global Hemotransmissive Infections Testing Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Others Case Studies
Figure 9. Hemotransmissive Infections Testing Report Years Considered
Figure 10. Global Hemotransmissive Infections Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Hemotransmissive Infections Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Hemotransmissive Infections Testing Market Share by Regions: 2020 VS 2027
Figure 13. Global Hemotransmissive Infections Testing Market Share by Regions (2022-2027)
Figure 14. Global Hemotransmissive Infections Testing Market Share by Players in 2020
Figure 15. Global Top Hemotransmissive Infections Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemotransmissive Infections Testing as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Hemotransmissive Infections Testing Revenue in 2020
Figure 17. Global Hemotransmissive Infections Testing Revenue Market Share by Type (2016-2021)
Figure 18. Global Hemotransmissive Infections Testing Revenue Market Share by Type (2022-2027)
Figure 19. North America Hemotransmissive Infections Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Hemotransmissive Infections Testing Market Share by Type (2016-2027)
Figure 21. North America Hemotransmissive Infections Testing Market Share by Application (2016-2027)
Figure 22. North America Hemotransmissive Infections Testing Market Share by Country (2016-2027)
Figure 23. United States Hemotransmissive Infections Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Hemotransmissive Infections Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Hemotransmissive Infections Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Hemotransmissive Infections Testing Market Share by Type (2016-2027)
Figure 27. Europe Hemotransmissive Infections Testing Market Share by Application (2016-2027)
Figure 28. Europe Hemotransmissive Infections Testing Market Share by Country (2016-2027)
Figure 29. Germany Hemotransmissive Infections Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Hemotransmissive Infections Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Hemotransmissive Infections Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Hemotransmissive Infections Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Hemotransmissive Infections Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Hemotransmissive Infections Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Hemotransmissive Infections Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Hemotransmissive Infections Testing Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Hemotransmissive Infections Testing Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Hemotransmissive Infections Testing Market Share by Region (2016-2027)
Figure 39. China Hemotransmissive Infections Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Hemotransmissive Infections Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Hemotransmissive Infections Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Hemotransmissive Infections Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Hemotransmissive Infections Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Hemotransmissive Infections Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Hemotransmissive Infections Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Hemotransmissive Infections Testing Market Share by Type (2016-2027)
Figure 47. Latin America Hemotransmissive Infections Testing Market Share by Application (2016-2027)
Figure 48. Latin America Hemotransmissive Infections Testing Market Share by Country (2016-2027)
Figure 49. Mexico Hemotransmissive Infections Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Hemotransmissive Infections Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Hemotransmissive Infections Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Hemotransmissive Infections Testing Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Hemotransmissive Infections Testing Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Hemotransmissive Infections Testing Market Share by Country (2016-2027)
Figure 55. Turkey Hemotransmissive Infections Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Hemotransmissive Infections Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Hemotransmissive Infections Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Vector-Best Revenue Growth Rate in Hemotransmissive Infections Testing Business (2016-2021)
Figure 59. Atlas Medical Revenue Growth Rate in Hemotransmissive Infections Testing Business (2016-2021)
Figure 60. Launch Diagnostics Revenue Growth Rate in Hemotransmissive Infections Testing Business (2016-2021)
Figure 61. Creative Diagnostics Revenue Growth Rate in Hemotransmissive Infections Testing Business (2016-2021)
Figure 62. Shanghai Chemtron Biotech Revenue Growth Rate in Hemotransmissive Infections Testing Business (2016-2021)
Figure 63. Oscar Medicare Revenue Growth Rate in Hemotransmissive Infections Testing Business (2016-2021)
Figure 64. ABON Biopharm Revenue Growth Rate in Hemotransmissive Infections Testing Business (2016-2021)
Figure 65. Bio-Rad Laboratories Revenue Growth Rate in Hemotransmissive Infections Testing Business (2016-2021)
Figure 66. Trinity Biotech Manufacturing Revenue Growth Rate in Hemotransmissive Infections Testing Business (2016-2021)
Figure 67. Adaltis Revenue Growth Rate in Hemotransmissive Infections Testing Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---